# US 2021/0171918 A1 · APPLICATION OF GLUTAMATE DEHYDROGENASE GDHA OF PEPTOSTREPTOCOCCUS ASACCHAROLYTICUS IN INCREASING YIELD OF POLY- r -GLUTAMIC ACID FROM BACILLUS LICHENIFORMIS

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171918 A1
- Document ID: US20210171918A1
- Status: Published application
- Kind: A1
- Application number: 17/037,671
- Filed: 2020-09-30
- Published: 2021-06-10
- Earliest claimed: 2019-12-05
- Assignees: Hubei University
- Applicants: Hubei University
- Inventors: Shouwen CHEN; Fan YANG; Dongbo CAI; Yaozhong CHEN; Qing ZHANG; Xin MA; Jiangang CHEN
- Web page: https://patentgrep.com/patent/US20210171918A1

## CPC

- C12N 9/0016: {with NAD or NADP as acceptor (1.4.1)}
- C12N 1/205: Bacterial isolates
- C12N 1/38: Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N1/34 takes precedence)
- C12P 13/02: Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12Y 104/01002: Glutamate dehydrogenase (1.4.1.2)
- C12Y 104/01003: Glutamate dehydrogenase (NAD(P)+)(1.4.1.3)
- C12Y 104/01004: Glutamate dehydrogenase (NADP+) (1.4.1.4)
- C12R 2001/10: Bacillus licheniformis
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Application of glutamate dehydrogenase GdhA of Peptostreptococcus asaccharolyticus in increasing the yield of poly-γ-glutamic acid from Bacillus licheniformis. The glutamate dehydrogenase GdhA of the Bacillus licheniformis WX-02 per se is replaced with the glutamate dehydrogenase derived from the Peptostreptococcus asaccharolyticus by means of homologous recombination, which significantly increases the level of synthesizing the poly-γ-glutamic acid for the Bacillus licheniformis, and the yield of the obtained poly-γ-glutamic acid from strains is increased at least by more than 20% compared with control strains.

## Claims

### Claim 1

A method for increasing yield of poly-γ-glutamic acid produced by Bacillus licheniformis through fermentation, comprising:
replacing a glutamate dehydrogenase gene in Bacillus licheniformis with a glutamate dehydrogenase gene of Peptostreptococcus asaccharolyticus to obtain a recombinant strain,
producing the poly-γ-glutamic acid through fermentation of the recombinant strain.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the Bacillus licheniformis is Bacillus licheniformis WX-02 with CCTCC Accession No. M208065.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the glutamate dehydrogenase gene of the Peptostreptococcus asaccharolyticus is as shown in SEQ ID NO:2.

### Claim 4 (depends on 1)

The method according to claim 1, wherein fermentation media used during the fermentation comprises:
30-90 g/L of glucose, 0-30 g/L of sodium glutamate, 0-10 g/L of sodium citrate, 5-10 g/L of NaNO3, 0-10 g/L of NH4Cl, 0.5-1 g/L of K2HPO4.3H2O, 0.8-1.2 g/L of MgSO4.7H2O, 0.8-1.2 g/L of ZnSO4.7H2O, 0.1-0.2 g/L of MnSO4—H2O, and 0.8-1.2 g/L of CaCl2, wherein at most one of the sodium glutamate, the sodium citrate, and the ammonium chloride is optionally 0 in the content; or
18-22 g/L of glycerol, 25-35 g/L of sodium glutamate, 8-13 g/L of sodium citrate, 7-12 g/L of NaNO3, 8-12 g/L of NH4Cl, 0.8-1.2 g/L of K2HPO4.3H2O, 0.9-1.2 g/L of MgSO4.7H2O, 0.8-1.2 g/L of ZnSO4.7H2O, 0.1-0.25 g/L of MnSO4.H2O, and 0.5-1.5 g/L of CaCl2.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the fermentation media used during fermentation comprise:
30-90 g/L of glucose, 0-30 g/L of sodium glutamate, 9-10 g/L of sodium citrate, 9-10 g/L of NaNO3, 9-10 g/L of NH4Cl, 0.8-1 g/L of K2HPO4.3H2O, 0.8-1 g/L of MgSO4.7H2O, 0.8-1 g/L of ZnSO4.7H2O, 0.1-0.2 g/L of MnSO4—H2O, and 0.8-1.2 g/L of CaCl2, and
the sodium glutamate and the sodium citrate are not 0 in content at same time.

### Claim 6 (depends on 3)

The method according to claim 3, wherein a protein encoded by the glutamate dehydrogenase gene of the Peptostreptococcus asaccharolyticus is as shown in SEQ ID NO:1.

### Claim 7 (depends on 1)

The method according to claim 1, wherein a method for constructing the recombinant strain comprises:
(1) performing gene synthesis to obtain the gdhA gene according to a genomic DNA sequence of Peptostreptococcus asaccharolyticus DSM 20463, wherein the synthesized gdhA gene has a sequence shown in SEQ ID NO:2, and primers for amplifying the gene comprise T2-F2 of SEQ ID NO:3 and T2-R2 of SEQ ID NO:4,
amplifying an upstream homologous arm and a downstream homologous arm of a glutamate dehydrogenase gene rocG of the Bacillus licheniformis per se through PCR with a genomic DNA of the Bacillus licheniformis WX-02 as a template, wherein primers for amplifying the upstream homologous arm of the amplified gene rocG comprise T2-F1 of SEQ ID NO: 5 and T2-R1 of SEQ ID NO: 6; and primers for amplifying the downstream homologous arm of the amplified gene rocG comprise T2-F3 of SEQ ID NO: 7 and T2-R3 of SEQ ID NO: 8;
(2) linking the upstream homologous arm of the gene rocG, the amplified gdhA gene, and the downstream homologous arm of the gene rocG through overlap-extension PCR to form a target gene fragment, which has an order as follows: the upstream homologous arm of the gene rocG-the amplified gdhA gene-the downstream homologous arm of the gene rocG;
(3) performing double digestion on the target gene fragment using restriction endonucleases SacI and XbaI to obtain digested gene fragments, and meanwhile, performing double digestion on a plasmid T2(2)-Ori using the restriction endonucleases SacI and XbaI to obtain linear plasmid fragments;
(4) linking the digested target fragments obtained in step (3) with the linear plasmid fragments obtained in step (3) via T4-DNA ligases, and verifying correctness to obtain plasmids T2(2)-gdhA;
(5) transferring the plasmids T2(2)-gdhA into the Bacillus licheniformis WX-02, screening by media resistant to kanacillin to obtain transformants, and picking the plasmids from the transformants for colony PCR verification;
(6) transferring and culturing positive transformants obtained in step (5) on the media resistant to kanacillin at 45° C. 3 times, each for 12 hours, and performing colony PCR to detect single-exchange strains with T2-KYF of SEQ ID NO: 9 and gdhA-R of SEQ ID NO: 10 as primers; and
(7) inoculating and culturing strains obtained in step (5) and the single-exchange strains obtained in step (6) in a mixed manner, transferring and culturing the mixed strains in media containing no kanacillin at 37° C. several times, picking the transformants for colony PCR verification to obtain positive transformants, and performing DNA sequencing on the positive transformants for further verification, thereby obtaining successfully double-exchanged recombinant strains; and primers for colony verification T2-KYF of SEQ ID NO: 11 and T2-KYR of SEQ ID NO: 12.

### Claim 8 (depends on 4)

The method according to claim 4, wherein conditions for the fermentation comprise inoculating a bacterial liquid of the recombinant strains into the fermentation media at an inoculation amount of 3% by volume, and culturing at the speed of 230 r/min and at the temperature of 37° C. for a fermentation period of 36 hours.
